These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21034629)
1. Emergence of Klebsiella pneumoniae carbapenemase-producing Proteus mirabilis in Hangzhou, China. Sheng ZK; Li JJ; Sheng GP; Sheng JF; Li LJ Chin Med J (Engl); 2010 Sep; 123(18):2568-70. PubMed ID: 21034629 [TBL] [Abstract][Full Text] [Related]
2. A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. Ambretti S; Gaibani P; Caroli F; Miragliotta L; Sambri V New Microbiol; 2010 Jul; 33(3):281-2. PubMed ID: 20954450 [TBL] [Abstract][Full Text] [Related]
3. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573 [TBL] [Abstract][Full Text] [Related]
4. Plasmid-mediated, inducible AmpC beta-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis. Yong D; Lim Y; Song W; Choi YS; Park DY; Lee H; Yum JH; Lee K; Kim JM; Chong Y Diagn Microbiol Infect Dis; 2005 Sep; 53(1):65-70. PubMed ID: 15936167 [TBL] [Abstract][Full Text] [Related]
5. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800 [TBL] [Abstract][Full Text] [Related]
6. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital. Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475 [TBL] [Abstract][Full Text] [Related]
8. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Nadkarni AS; Schliep T; Khan L; Zeana CB Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Sabia C; Gargiulo R; Sarti M New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136 [TBL] [Abstract][Full Text] [Related]
10. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205 [TBL] [Abstract][Full Text] [Related]
11. Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients. Giani T; Antonelli A; Caltagirone M; Mauri C; Nicchi J; Arena F; Nucleo E; Bracco S; Pantosti A; ; Luzzaro F; Pagani L; Rossolini GM Euro Surveill; 2017 Aug; 22(31):. PubMed ID: 28797330 [TBL] [Abstract][Full Text] [Related]
12. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001. Boutiba-Ben Boubaker I; Ghozzi R; Ben Abdallah H; Mamlouk K; Kamoun A; Ben Redjeb S Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883 [TBL] [Abstract][Full Text] [Related]
14. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514 [TBL] [Abstract][Full Text] [Related]
15. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Bergamasco MD; Barroso Barbosa M; de Oliveira Garcia D; Cipullo R; Moreira JC; Baia C; Barbosa V; Abboud CS Transpl Infect Dis; 2012 Apr; 14(2):198-205. PubMed ID: 22093103 [TBL] [Abstract][Full Text] [Related]
16. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations. de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935 [No Abstract] [Full Text] [Related]
19. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. Curiao T; Morosini MI; Ruiz-Garbajosa P; Robustillo A; Baquero F; Coque TM; Cantón R J Antimicrob Chemother; 2010 Aug; 65(8):1608-14. PubMed ID: 20513703 [TBL] [Abstract][Full Text] [Related]
20. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Villegas MV; Lolans K; Correa A; Suarez CJ; Lopez JA; Vallejo M; Quinn JP; Antimicrob Agents Chemother; 2006 Aug; 50(8):2880-2. PubMed ID: 16870793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]